SHL.DE: Siemens Healthineers AG Financials
Siemens Healthineers AG Income Statement
Total revenue
Net income
Gross margin TTM
38.63%
Operating margin TTM
14.7%
Net profit margin TTM
9.17%
Return on investment TTM
11.88%
| Period end | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 |
|---|---|---|---|---|
| Total revenue | 23,375,000,000 | 22,363,000,000 | 21,680,000,000 | 21,714,000,000 |
| Operating income | 3,435,000,000 | 3,300,000,000 | 2,440,000,000 | 3,064,000,000 |
| Net income | 2,144,000,000 | 1,942,000,000 | 1,509,000,000 | 2,038,000,000 |
All line items
| Line item | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 |
|---|---|---|---|---|
| Total revenue | 23,375,000,000 | 22,363,000,000 | 21,680,000,000 | 21,714,000,000 |
| Cost of revenue | 14,345,000,000 | 13,895,000,000 | 13,971,000,000 | 13,577,000,000 |
| Gross profit | 9,030,000,000 | 8,468,000,000 | 7,709,000,000 | 8,137,000,000 |
| Research and development expenses | 1,958,000,000 | 1,918,000,000 | 1,866,000,000 | 1,785,000,000 |
| General and administrative expenses | 0 | 0 | 0 | 0 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 3,637,000,000 | 3,250,000,000 | 3,403,000,000 | 3,288,000,000 |
| Other expenses | 0 | 0 | 0 | 0 |
| Operating expenses | 5,595,000,000 | 5,168,000,000 | 5,269,000,000 | 5,073,000,000 |
| Cost and expenses | 19,940,000,000 | 19,063,000,000 | 19,240,000,000 | 18,650,000,000 |
| Net interest income | -326,000,000 | -357,000,000 | -211,000,000 | -70,000,000 |
| Interest income | 99,000,000 | 119,000,000 | 85,000,000 | 48,000,000 |
| Interest expense | 425,000,000 | 476,000,000 | 296,000,000 | 118,000,000 |
| Depreciation and amortization | 1,296,000,000 | 1,223,000,000 | 1,557,000,000 | 1,343,000,000 |
| EBITDA | 4,584,000,000 | 4,224,000,000 | 3,778,000,000 | 4,259,000,000 |
| EBIT | 3,288,000,000 | 3,001,000,000 | 2,221,000,000 | 2,916,000,000 |
| Non-operating income (excl. interest) | 147,000,000 | 299,000,000 | 219,000,000 | 148,000,000 |
| Operating income | 3,435,000,000 | 3,300,000,000 | 2,440,000,000 | 3,064,000,000 |
| Total other income/expenses (net) | -582,000,000 | -777,000,000 | -512,000,000 | -264,000,000 |
| Income before tax | 2,853,000,000 | 2,523,000,000 | 1,928,000,000 | 2,800,000,000 |
| Income tax expense | 685,000,000 | 564,000,000 | 403,000,000 | 746,000,000 |
| Net income from continuing operations | 2,168,000,000 | 1,959,000,000 | 1,525,000,000 | 2,054,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 2,144,000,000 | 1,942,000,000 | 1,509,000,000 | 2,038,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 2,144,000,000 | 1,942,000,000 | 1,509,000,000 | 2,038,000,000 |
| EPS | 2 | 2 | 1 | 2 |
| Diluted EPS | 2 | 2 | 1 | 2 |
| Weighted average shares outstanding | 1,119,828,000 | 1,116,091,954 | 1,119,472,000 | 1,122,794,000 |
| Weighted average diluted shares outstanding | 1,124,739,000 | 1,123,447,000 | 1,123,552,000 | 1,127,746,000 |
Siemens Healthineers AG Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
10,837,000,000%
Total debt / assets MRQ
—
| Period end | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 |
|---|---|---|---|---|
| Total assets | 44,370,000,000 | 46,055,000,000 | 46,684,000,000 | 49,056,000,000 |
| Total liabilities | 26,279,000,000 | 27,807,000,000 | 28,551,000,000 | 29,204,000,000 |
| Total equity | 18,040,000,000 | 18,199,000,000 | 18,081,000,000 | 19,836,000,000 |
All line items
| Line item | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 |
|---|---|---|---|---|
| Cash and cash equivalents | 2,175,000,000 | 2,683,000,000 | 1,642,000,000 | 1,436,000,000 |
| Short-term investments | 0 | 0 | 0 | 0 |
| Cash and short-term investments | 2,175,000,000 | 2,683,000,000 | 1,642,000,000 | 1,436,000,000 |
| Net receivables | 7,265,000,000 | 7,205,000,000 | 7,484,000,000 | 7,064,000,000 |
| Accounts receivable | 6,472,000,000 | 6,296,000,000 | 6,049,000,000 | 5,631,000,000 |
| Other receivables | 793,000,000 | 909,000,000 | 1,435,000,000 | 1,433,000,000 |
| Inventory | 4,135,000,000 | 4,179,000,000 | 4,294,000,000 | 4,009,000,000 |
| Prepaid expenses | 185,000,000 | 180,000,000 | 206,000,000 | 187,000,000 |
| Other current assets | 338,000,000 | 196,000,000 | 510,000,000 | 683,000,000 |
| Total current assets | 14,098,000,000 | 14,443,000,000 | 14,136,000,000 | 13,379,000,000 |
| Property, plant and equipment (net) | 4,713,000,000 | 4,476,000,000 | 4,210,000,000 | 4,273,000,000 |
| Goodwill | 17,124,000,000 | 17,662,000,000 | 18,118,000,000 | 19,061,000,000 |
| Intangible assets | 6,505,000,000 | 7,062,000,000 | 7,726,000,000 | 8,712,000,000 |
| Goodwill and intangible assets | 23,629,000,000 | 24,724,000,000 | 25,844,000,000 | 27,773,000,000 |
| Long-term investments | 976,000,000 | 1,405,000,000 | 1,598,000,000 | 2,610,000,000 |
| Tax assets | 410,000,000 | 476,000,000 | 416,000,000 | 575,000,000 |
| Other non-current assets | 544,000,000 | 531,000,000 | 480,000,000 | 446,000,000 |
| Total non-current assets | 30,272,000,000 | 31,612,000,000 | 32,548,000,000 | 35,677,000,000 |
| Other assets | 0 | 0 | 0 | 0 |
| Total assets | 44,370,000,000 | 46,055,000,000 | 46,684,000,000 | 49,056,000,000 |
| Total payables | 2,971,000,000 | 2,517,000,000 | 2,665,000,000 | 2,924,000,000 |
| Accounts payable | 2,296,000,000 | 2,126,000,000 | 2,203,000,000 | 2,315,000,000 |
| Other payables | 675,000,000 | 391,000,000 | 462,000,000 | 609,000,000 |
| Accrued expenses | 1,339,000,000 | 1,437,000,000 | 1,435,000,000 | 1,280,000,000 |
| Short-term debt | 3,720,000,000 | 2,754,000,000 | 4,395,000,000 | 2,842,000,000 |
| Capital lease obligations (current) | 0 | 0 | 0 | 0 |
| Tax payables | 0 | 391,000,000 | 849,000,000 | 960,000,000 |
| Deferred revenue | 3,641,000,000 | 3,628,000,000 | 3,627,000,000 | 3,749,000,000 |
| Other current liabilities | 973,000,000 | 1,237,000,000 | 1,318,000,000 | 1,229,000,000 |
| Total current liabilities | 12,644,000,000 | 11,573,000,000 | 13,440,000,000 | 12,024,000,000 |
| Long-term debt | 10,837,000,000 | 12,922,000,000 | 11,809,000,000 | 13,343,000,000 |
| Capital lease obligations (non-current) | 505,000,000 | 533,000,000 | 449,000,000 | 468,000,000 |
| Deferred revenue (non-current) | 0 | 0 | 0 | 0 |
| Deferred tax liabilities (non-current) | 1,150,000,000 | 1,510,000,000 | 1,663,000,000 | 2,110,000,000 |
| Other non-current liabilities | 1,143,000,000 | 1,269,000,000 | 1,190,000,000 | 1,259,000,000 |
| Total non-current liabilities | 13,635,000,000 | 16,234,000,000 | 15,111,000,000 | 17,180,000,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 505,000,000 | 533,000,000 | 449,000,000 | 468,000,000 |
| Total liabilities | 26,279,000,000 | 27,807,000,000 | 28,551,000,000 | 29,204,000,000 |
| Treasury stock | -539,000,000 | -433,000,000 | -607,000,000 | -405,000,000 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 1,128,000,000 | 1,128,000,000 | 1,128,000,000 | 1,128,000,000 |
| Retained earnings | 3,240,000,000 | 2,154,000,000 | 1,381,000,000 | 894,000,000 |
| Additional paid-in capital | 15,888,000,000 | 15,872,000,000 | 15,839,000,000 | 15,861,000,000 |
| Accumulated other comprehensive income/loss | -1,677,000,000 | -522,000,000 | 340,000,000 | 2,358,000,000 |
| Other stockholders' equity | 0 | 0 | 0 | 0 |
| Total stockholders' equity | 18,040,000,000 | 18,199,000,000 | 18,081,000,000 | 19,836,000,000 |
| Total equity | 18,091,000,000 | 18,248,000,000 | 18,133,000,000 | 19,852,000,000 |
| Minority interest | 51,000,000 | 49,000,000 | 52,000,000 | 16,000,000 |
| Total liabilities and total equity | 44,370,000,000 | 46,055,000,000 | 46,684,000,000 | 49,056,000,000 |
| Total investments | 976,000,000 | 1,405,000,000 | 1,598,000,000 | 2,610,000,000 |
| Total debt | 15,062,000,000 | 16,209,000,000 | 16,653,000,000 | 16,653,000,000 |
| Net debt | 12,887,000,000 | 13,526,000,000 | 15,011,000,000 | 15,217,000,000 |
Siemens Healthineers AG Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 |
|---|---|---|---|---|
| Cash from operations | 3,083,000,000 | 2,469,000,000 | 1,809,000,000 | 2,256,000,000 |
| Cash from investing | -906,000,000 | -666,000,000 | -1,069,000,000 | -868,000,000 |
| Cash from financing | -2,589,000,000 | -1,300,000,000 | -380,000,000 | -1,396,000,000 |
| Net change in cash | -508,000,000 | 1,041,000,000 | 206,000,000 | 114,000,000 |
All line items
| Line item | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 |
|---|---|---|---|---|
| Net income | 2,144,000,000 | 1,942,000,000 | 1,509,000,000 | 2,037,000,000 |
| Depreciation and amortization | 1,296,000,000 | 1,223,000,000 | 1,557,000,000 | 1,343,000,000 |
| Deferred income tax | -301,000,000 | -204,000,000 | -265,000,000 | -266,000,000 |
| Stock-based compensation | 0 | 0 | 0 | 0 |
| Change in working capital | -581,000,000 | -605,000,000 | -842,000,000 | -1,125,000,000 |
| Accounts receivable | -410,000,000 | -422,000,000 | -773,000,000 | -489,000,000 |
| Inventory | -76,000,000 | 39,000,000 | -453,000,000 | -481,000,000 |
| Accounts payable | 229,000,000 | -62,000,000 | -20,000,000 | 247,000,000 |
| Other working capital | -324,000,000 | -160,000,000 | 404,000,000 | -402,000,000 |
| Other non-cash items | 525,000,000 | 113,000,000 | -150,000,000 | 267,000,000 |
| Net cash from operating activities | 3,083,000,000 | 2,469,000,000 | 1,809,000,000 | 2,256,000,000 |
| Investments in property, plant and equipment | -818,000,000 | -696,000,000 | -838,000,000 | -852,000,000 |
| Acquisitions (net) | -86,000,000 | 34,000,000 | -224,000,000 | -14,000,000 |
| Purchases of investments | -2,000,000 | -4,000,000 | -7,000,000 | -2,000,000 |
| Sales/maturities of investments | 0 | 0 | 0 | 0 |
| Other investing activities | 0 | 0 | 0 | 0 |
| Net cash from investing activities | -906,000,000 | -666,000,000 | -1,069,000,000 | -868,000,000 |
| Net debt issuance | -1,197,000,000 | -211,000,000 | 1,104,000,000 | -114,000,000 |
| Long-term net debt issuance | -132,000,000 | -216,000,000 | -190,000,000 | -149,000,000 |
| Short-term net debt issuance | -1,065,000,000 | 5,000,000 | 1,294,000,000 | 35,000,000 |
| Net stock issuance | -301,000,000 | -10,000,000 | -403,000,000 | -308,000,000 |
| Net common stock issuance | -301,000,000 | -10,000,000 | -403,000,000 | -308,000,000 |
| Common stock issuance | 0 | 0 | 18,000,000 | 1,000,000 |
| Common stock repurchased | -301,000,000 | -10,000,000 | -421,000,000 | -309,000,000 |
| Net preferred stock issuance | 0 | 0 | 0 | 0 |
| Net dividends paid | -1,066,000,000 | -1,063,000,000 | -1,066,000,000 | -955,000,000 |
| Common dividends paid | -1,066,000,000 | -1,063,000,000 | -1,066,000,000 | -955,000,000 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
| Other financing activities | -25,000,000 | -16,000,000 | -15,000,000 | -19,000,000 |
| Net cash from financing activities | -2,589,000,000 | -1,300,000,000 | -380,000,000 | -1,396,000,000 |
| Effect of FX changes on cash | -96,000,000 | 538,000,000 | -154,000,000 | 122,000,000 |
| Net change in cash | -508,000,000 | 1,041,000,000 | 206,000,000 | 114,000,000 |
| Cash at end of period | 2,175,000,000 | 2,683,000,000 | 1,642,000,000 | 1,436,000,000 |
| Cash at beginning of period | 2,683,000,000 | 1,642,000,000 | 1,436,000,000 | 1,322,000,000 |
| Operating cash flow | 3,083,000,000 | 2,469,000,000 | 1,809,000,000 | 2,256,000,000 |
| Capital expenditure | -818,000,000 | -696,000,000 | -838,000,000 | -852,000,000 |
| Free cash flow | 2,265,000,000 | 1,773,000,000 | 971,000,000 | 1,404,000,000 |
| Income taxes paid | 0 | 0 | 0 | 0 |
| Interest paid | 0 | 0 | 0 | 0 |